Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACCESS+ Strategy for Hepatitis C in Cameroon
NCT07098481Phase 4Not yet recruiting
- Sponsor
- ANRS
- Start
- Sep 2025
- Primary completion
- Dec 2027
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of sofosbuvir + velpatasvir, sofosbuvir + velpatasvir + voxilaprevir in hepatitis C (HCV), sponsored by ANRS. Planned start Sep 2025; status: not yet recruiting.
02
Drugs
sofosbuvir + velpatasvirsofosbuvir + velpatasvir + voxilaprevir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT07098481.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07098481.